LTC facilities generally care for patients that are critically and/orterminally ill, bed-ridden, and that show higher rates of dementia; allindicators that put an individual at risk for developing a pressure ulcer.TMI's thermal imaging diagnostic device will equip caregivers at thesefacilities with the ability to objectively identify patterns of injuryassociated with the development of pressure ulcers. This kind of earlydetection can lead to intervention and even prevention. By identifying thetissue changes associated with the development of these wounds prior toskin breakdown, a patient can receive considerably better care by avoidinga pressure ulcer occurrence altogether. When long-term care facilitiesreduce the occurrence of pressure ulcers within their facility, theyreceive a higher rating in the pay for performance ("P4P") initiative fromthe Centers for Medicare & Medicaid Services ("CMS").

LTC facilities that utilize TMI's thermal imaging system technology will beable to provide better overall patient care by significantly lowering theirpressure ulcer incident rate. By having complete documentation of everyskin assessment performed, an LTC facility can also curtail its liabilitiesby protecting itself against costly lawsuits.

With nearly 16,000 long-term care facilities in the United States, and anaging population that is increasing in size year after year, TMI has anenormous and largely untouched market to go after with its revolutionarysystem. TMI's marketing plan includes a program where LTC facilities canlease the equipment necessary to perform skin assessments and store thenecessary data onsite. Lease plans start at the monthly fee of $2,000 perunit. This monthly fee allows for unlimited imaging, a factor that shouldhelp promote aggressive imaging/assessment programs by these facilities.

Wellstar/TMI CEO, John Antonio, commented: "We have already seen a positiveresponse to our thermal imaging system among the LTC facilities we havebeen engaged with. We expect significant revenue potential within the LTCmarket, and the Company anticipates placing initial units within thesefacilities sometime within the first quarter of 2009."

The company has developed its thermal imaging system for variousapplications. The TMI technology and software has been approved by the FDAas an Adjunctive Diagnostic Screening Procedure for early breast cancerdetection, differential diagnoses of pain dysfunctions (such as ReflexSympathetic Dystrophy, Neuromuscular Skeletal Syndromes and neurologicaldisorders), for the early detection of pressure ulcers, deep tissueinjuries, and bedsores, as well as for orthopedic applications. The companyhas plans to market diagnostic systems for all of the above mentionedapplications.

ABOUT WELLSTAR INTERNATIONAL, INC.:

Wellstar International, Inc., through its wholly owned operating subsidiaryTrillennium Medical Imaging, Inc. (TMI), is poised to become a leadingdiagnostic company in the health care industry. TMI has developed and ismarketing fully calibrated and functional, thermal imaging systems thatutilize state-of-the-art infrared technologies and proprietary software toaccurately and cost-effectively measure physiological changes in the humanbody. More information on the Company and its unique diagnostic softwareand product line is available on Wellstar's corporate Website, by visiting:www.wellstar.us.

FORWARD-LOOKING STATEMENTS:

This press release contains statements, which may constitute'forward-looking statements' within the meaning of the Securities Act of1933 and the Securities Exchange Act of 1934, as amended by the PrivateSecurities Litigation Reform Act of 1995. Prospective investors arecautioned that any such forward-looking statements are not guarantees offuture performance and involve risks and uncertainties, and that actualresults may differ materially from those contemplated by suchforward-looking statements. Important factors currently known to managementthat could cause actual results to differ materially from those inforward-statements include fluctuation of operating results, the ability tocompete successfully and the ability to complete before-mentionedtransactions. The company undertakes no obligation to update or reviseforward-looking statements to reflect changed assumptions, the occurrenceof unanticipated events or changes to future operating results.

CONTACT:Equiti-trend Advisors LLC(800) 953-3350 Toll-Free, U.S. & Canada(858) 436-3350 Local or International9:30 a.m. to 5:00 p.m. EST